Benjamin Haynor
Stock Analyst at Lake Street
(0.49)
# 3,856
Out of 4,820 analysts
10
Total ratings
33.33%
Success rate
-18.69%
Average return
Main Sectors:
Stocks Rated by Benjamin Haynor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PROF Profound Medical | Maintains: Buy | $17 → $11 | $4.75 | +131.58% | 1 | Apr 23, 2025 | |
| VSAT Viasat | Maintains: Buy | $31 → $19 | $9.04 | +110.18% | 5 | Sep 20, 2024 | |
| CGNT Cognyte Software | Downgrades: Hold | n/a | $9.68 | - | 2 | Mar 13, 2018 | |
| DRIO DarioHealth | Initiates: Buy | $70 | $0.80 | +8,652.19% | 1 | Aug 29, 2017 | |
| SRDX Surmodics | Initiates: Buy | $44 | $29.46 | +47.66% | 1 | Jun 27, 2017 |
Profound Medical
Apr 23, 2025
Maintains: Buy
Price Target: $17 → $11
Current: $4.75
Upside: +131.58%
Viasat
Sep 20, 2024
Maintains: Buy
Price Target: $31 → $19
Current: $9.04
Upside: +110.18%
Cognyte Software
Mar 13, 2018
Downgrades: Hold
Price Target: n/a
Current: $9.68
Upside: -
DarioHealth
Aug 29, 2017
Initiates: Buy
Price Target: $70
Current: $0.80
Upside: +8,652.19%
Surmodics
Jun 27, 2017
Initiates: Buy
Price Target: $44
Current: $29.46
Upside: +47.66%